In June 2017, the Supreme Court issued its decision in Bristol-Myers Squibb Co. v. Superior Court, 137 S. Ct. 1773 (2017), which concerned personal jurisdiction over nonresident defendants for claims brought by nonresident plaintiffs in a California state court mass tort action. In the wake of the Bristol-Myers decision, the case law has been rapidly developing in the district courts in putative class actions where, in reliance on Bristol-Myers, defendants have challenged the courts’ jurisdiction where nonresident plaintiffs assert claims against nonresident defendants not subject to general jurisdiction.
May 21, 2018 Articles
Bristol-Myers Squibb Co. v. Superior Court: Federal District Courts Begin Weighing In
The majority of courts have held that they do not have personal jurisdiction over nonresident defendants for claims brought by nonresident plaintiffs.
By Katherine S. Kayatta
Premium Content For:
- Litigation Section